Product Information
OXCARBAZEPINE 300 MG/5 ML SUSP is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1168 per ML under NDC 67877053258. Its NADAC has been published 67 times since May 14, 2025.
FDA first approved this application on Mar 18, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/mL
Manufacturer
Ascend Laboratories, LLCNDC
67877053258
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXCARBAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA213183FDA Approved
3/18/2023
TE Code
AB
On Market Since
1/1/2020
Pharmacological Classes
Price Statistics
The NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has been published 67 times since May 14, 2025, and over the history we have for it it has declined 49.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1168 per ML |
|---|---|
| All-time high | $0.2400 (Jun 11, 2025) |
| All-time low | $0.1168 (Aug 19, 2026) |
| 52-week high | $0.1754 |
| 52-week low | $0.1168 |
| Median price | $0.1448 |
| Average price | $0.1613 |
| Largest weekly change | -15.8% (Aug 20, 2025) |
| Weeks tracked | 67 |
| Tracking since | May 14, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Oxcarbazepine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXCARBAZEPINE 300 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 300 MG/5 ML SUSP, manufactured by Ascend Laboratories, LLC, is $0.1168 per ML (NDC 67877053258), effective Aug 19, 2026.
How has the price of OXCARBAZEPINE 300 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has declined 49.1%. It has been tracked across 67 weekly CMS publications since May 14, 2025.
What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 300 MG/5 ML SUSP?
Since May 14, 2025, the NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has ranged from a low of $0.1168 (Aug 19, 2026) to a high of $0.2400 (Jun 11, 2025), with a median of $0.1448 per ML.
Are there cheaper alternatives to OXCARBAZEPINE 300 MG/5 ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of OXCARBAZEPINE 300 MG/5 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OXCARBAZEPINE 300 MG/5 ML SUSP?
OXCARBAZEPINE 300 MG/5 ML SUSP (NDC 67877053258) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.